CLN-301

N/A

Report date: 2025/05/13 14:55:13

Base Information

Drug NameCLN-301
Drug Alias NameCLN-301
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionBattenin modulators
TargetsBattenin
Therapy Area/IndicationsNeuronal Ceroid-Lipofuscinoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesAlcyone Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlcyone Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeuronal Ceroid-Lipofuscinoses
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A